DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 939 filers reported holding DANAHER CORPORATION in Q4 2014. The put-call ratio across all filers is 0.82 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $205,627 | +24.6% | 823 | +24.5% | 0.01% | +16.7% |
Q1 2024 | $165,065 | -28.0% | 661 | -33.3% | 0.01% | -33.3% |
Q4 2023 | $229,258 | +161.8% | 991 | +180.7% | 0.01% | +125.0% |
Q3 2023 | $87,579 | -99.3% | 353 | -99.3% | 0.00% | -99.3% |
Q2 2023 | $12,820,560 | +1.6% | 53,419 | +6.7% | 0.56% | -6.4% |
Q1 2023 | $12,618,131 | +3768.2% | 50,064 | +3973.6% | 0.60% | +3216.7% |
Q4 2022 | $326,201 | +4.2% | 1,229 | +1.3% | 0.02% | -5.3% |
Q3 2022 | $313,000 | +1.6% | 1,213 | 0.0% | 0.02% | +5.6% |
Q2 2022 | $308,000 | -79.9% | 1,213 | -87.9% | 0.02% | -89.0% |
Q4 2019 | $1,529,000 | -74.2% | 10,003 | -76.2% | 0.16% | -46.7% |
Q3 2019 | $5,937,000 | +77.6% | 42,117 | +79.2% | 0.31% | +16.8% |
Q2 2019 | $3,343,000 | +9.6% | 23,503 | 0.0% | 0.26% | +4.4% |
Q1 2019 | $3,050,000 | -31.3% | 23,503 | -46.1% | 0.25% | -54.0% |
Q4 2018 | $4,440,000 | +225.3% | 43,625 | +244.0% | 0.55% | +574.1% |
Q3 2018 | $1,365,000 | -77.3% | 12,682 | -79.1% | 0.08% | -78.3% |
Q2 2018 | $6,024,000 | +24.7% | 60,575 | +20.5% | 0.37% | +89.8% |
Q1 2018 | $4,831,000 | -14.5% | 50,269 | -16.3% | 0.20% | -9.6% |
Q4 2017 | $5,651,000 | -67.7% | 60,048 | -70.7% | 0.22% | -69.5% |
Q3 2017 | $17,478,000 | +183.6% | 204,896 | +232.0% | 0.71% | +161.5% |
Q2 2017 | $6,162,000 | -7.2% | 61,722 | -20.6% | 0.27% | +3.8% |
Q1 2017 | $6,643,000 | -48.9% | 77,780 | -52.9% | 0.26% | -56.5% |
Q4 2016 | $12,996,000 | +309.8% | 165,231 | +423.2% | 0.60% | +110.1% |
Q2 2016 | $3,171,000 | -82.5% | 31,583 | -85.2% | 0.29% | -70.3% |
Q3 2015 | $18,097,000 | +21.5% | 213,615 | +22.5% | 0.97% | +35.9% |
Q1 2015 | $14,890,000 | +320.5% | 174,335 | +325.4% | 0.71% | +345.6% |
Q4 2014 | $3,541,000 | +7.6% | 40,980 | -5.2% | 0.16% | +5.3% |
Q3 2014 | $3,291,000 | -62.4% | 43,225 | -61.1% | 0.15% | -60.2% |
Q2 2014 | $8,753,000 | +158.4% | 111,240 | +145.8% | 0.38% | +52.2% |
Q1 2014 | $3,387,000 | – | 45,248 | – | 0.25% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |